DexCom, Inc. (DXCM)

Healthcare
$83.45▲ 8.91 (11.95%)
Real-time prices · US Markets
📅
Next earnings: Oct 29
Bullish
8 / 10
High-quality business with 38% return on equity and 20% profit margins.
Quality
9.3
Health
7.6
Growth
8.9
Valuation
5.8
Sentiment
8.4
Analyst Target
$86.16
▲ +3.2% from current

Price Chart

Fundamentals

Trailing P/E
33.0×
price-to-earnings
Forward P/E
26.8×
next 12 months est.
Market Cap
$31.5B
market capitalization
Div Yield
dividend yield
Profit Margin
20.1%
net profit margin
Gross Margin
62.5%
revenue minus COGS
ROE
38.5%
return on equity
Beta
1.45
vs S&P 500
52-Week Range
$54 — $85
annual min — max

EPS — Estimate vs Actual

Frequently Asked Questions

What do analysts say about DexCom, Inc. right now?
DexCom, Inc.'s Q·Score is 8/10 (Bullish), reflecting its current fundamentals, analyst data, and valuation metrics. High-quality business with 38% return on equity and 20% profit margins. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.
What is the analyst price target for DXCM?
The consensus price target for DXCM is $86.16, based on ratings from 25 Wall Street analysts. This is 3.2% above the current price of $83.45. Price targets are forward-looking estimates and not guarantees of future performance.
Is DXCM overvalued or undervalued?
DexCom, Inc. (DXCM) scores in line with sector averages on valuation metrics. Its forward P/E ratio stands at 26.8×.
When does DexCom, Inc. report its next earnings?
DexCom, Inc.'s next earnings report is expected on approximately October 29, 2026.
What is DexCom, Inc.'s profit margin?
DexCom, Inc. has a net profit margin of 20.1%, which is considered high and reflects strong pricing power. Its gross margin stands at 62.5%, indicating a high-margin business model.
Is DexCom, Inc.'s revenue growing?
DexCom, Inc. is reporting solid revenue growth of 13.1% year-over-year. Earnings are also growing at 43.6%, indicating improving profitability.
How much debt does DexCom, Inc. have?
DexCom, Inc. has a debt-to-equity ratio of 0.53×, reflecting a moderate debt level, which is manageable for most profitable companies. Its current ratio is 1.73×, indicating comfortable short-term liquidity.
Data provided by Yahoo Finance ·  Updated on each page load ·  For informational purposes only · Not financial advice · Quantify.biz © 2026